Active Funding Opportunities and Notices for NICHD

NICHD publishes and participates in various notices of funding opportunities (NOFOs) and NIH Guide Notices (NOTs) to support research and training activities.

NOTs and Active NOFOs for NICHD

Please note: the following are sorted by date, from most recent to older. Select a table heading to change how to sort the information.

Number Exp. Date Sort ascending Activity Code(s) Title
NOT-NS-15-020 January 1, 2027 Request for Information (RFI) on the Proposed Funding Priorities for Neuroscience Research, Input on High Impact and Cross-Cutting Opportunities (NIH Neuroscience Blueprint)
NOT-NS-15-014 January 1, 2027 Request for Information (RFI) on the Draft 2015 Action Plan for the Muscular Dystrophies
NOT-NS-14-039 January 1, 2027 Request for Information (RFI) on the Action Plan for the Muscular Dystrophies
NOT-NS-14-021 January 1, 2027 Notice of Intent to Publish a Funding Opportunity Announcement for the "Blueprint Neurotherapeutics Network (BPN): SBIR Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44)"
NOT-RM-12-002 January 1, 2027 Notice of Revision for RFA-RM-11-008, Human Heredity and Health in Africa (H3Africa): Collaborative Centers (U54)

NOT-NS-18-073 January 1, 2027 Administrative Supplements for Validation of Novel Non-Addictive Pain Targets (Clinical Trials Not Allowed)
NOT-NS-18-075 January 1, 2027 Soliciting Feedback on the BRAIN Initiative
NOT-NS-18-086 January 1, 2027 Notice of Change of Receipt Date for RFA-NS-18-019 "BRAIN Initiative: Optimization of Transformative Technologies for Large Scale Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed)"
NOT-NS-18-087 January 1, 2027 Notice of Change of Receipt Date for RFA-NS-18-020 "BRAIN Initiative: New Technologies and Novel Approaches for Large-Scale Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed)"
NOT-NS-18-088 January 1, 2027 Notice of Change of Receipt Date for RFA-EY-18-001 "BRAIN Initiative: New Concepts and Early - Stage Research for Large - Scale Recording and Modulation in the Nervous System (R21 Clinical Trial Not Allowed)"
NOT-NS-19-002 January 1, 2027 Request for Information (RFI) on the Proposed Funding Priorities for Neuroscience Research, Input on Cross-Cutting Opportunities (NIH Neuroscience Blueprint)
NOT-NS-19-009 January 1, 2027 Notice of Intent to Publish a Funding Opportunity Announcement for Translational Devices to Treat Pain (UG3/UH3 Clinical Trial Optional)
NOT-NS-19-010 January 1, 2027 Notice of Intent to Publish a Funding Opportunity Announcement for Translational Devices to Treat Pain (U44 Clinical Trial Optional)
NOT-NS-19-014 January 1, 2027 HEAL Initiative: Notice of Interest in Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Applications Directed at Enhanced Pain Management and Improved Treatments for Opioid Misuse and Addiction
NOT-NS-19-022 January 1, 2027 Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Pain Effectiveness Research Network: Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
NOT-NS-19-029 January 1, 2027 Notice of Interest in Advancing Research in Acute Flaccid Myelitis and Guillain-Barre Syndrome
NOT-NS-19-034 January 1, 2027 Notice of Change to Key Dates for RFA-NS-18-014 "BRAIN Initiative: Targeted BRAIN Circuits Planning Projects - TargetedBCPP (R34 Clinical Trial Not Allowed)"
NOT-NS-19-038 January 1, 2027 Notice of Pre-Application Webinar and FAQs for RFA-NS-19-022, "Biological Measures for Prognosing and Monitoring of Persistent Concussive Symptoms in Early and Middle Adolescents: Center Without Walls (PCS-EMA CWOW) (U54 Clinical Trial Not Allowed)
NOT-NS-19-041 January 1, 2027 Request for Information on the Proposal for Updating the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative Plan
NOT-NS-19-053 January 1, 2027 Notice of Change to Key Dates for RFA-NS-19-016 "HEAL Initiative: Translational Devices to Treat Pain (UG3/UH3 Clinical Trial Optional)"
top of pageBACK TO TOP